Vinge has advised the fintech company Anyfin AB in connection with an investment round of approximately MSEK 80, in which new and existing investors are participating including, among others, Accel, Northzone, Global Founders Capital and Fintech Collective.
The board of directors of Jays Group AB (publ) has resolved pursuant to authorization granted at an annual general meeting to perform a new issue of shares amounting to approximately MSEK 41 subject to pre-emption rights for the company’s existing shareholders.
Creades AB (publ) has sold 4,250,000 shares in Lindab International AB (publ) at SEK 100 per share (in total SEK 425 million) through an accelerated bookbuilt offering to institutional investors.
Vinge has advised Vostok New Ventures Ltd with capital markets related questions in light of the company’s divestment of its portfolio asset Avito, for in total USD 540 million, equivalent of approximately SEK 4,842 million, as well as in connection with the subsequent split and mandatory redemption program whereby each depository receipt holder (“SDRs”) will receive a cash consideration of SEK 25 per SDR.
Vinge has advised Strax AB in connection with an automatic redemption procedure according to which each outstanding share in Strax has been split into two shares, of which one share (called redemption share) has been redeemed for a proceed of SEK 1.10.
The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 546 million, before issue costs.
